Mitsubishi Tanabe's DPP-4 inhibitor teneligliptin filed in first market
02 September 2011
Ian Haydock
Please Login to read the full article.
02 September 2011
Ian Haydock
ian.haydock@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- EC approval for BI/Lilly's one-dosage Trajenta for type 2 diabetes
- Three month review delay in US sets Takeda's alogliptin further back in diabetes
- DSP aims to extend Japan repaglinide use through new filing
- Comparator choice scuppers BI/Lilly's Trajenta assessment in Germany
ANALYSIS
Other Informa Analysis
FEATURES
Other Informa Features
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
